Our vision is to provide accessible and equitable infectious disease diagnostic testing and surveillance for all populations.
Our mission is to iterate on the creation of accessible, easy-to-deploy infectious disease diagnostic testing models that enable sufficient testing volumes from a variety of populations to drive testing, collection, surveillance research, and strategy.
The COVID-19 pandemic continues to impact people, our economy, and our health and social systems. Until we have a vaccine, research and testing are key.
McMaster HealthLabs (MHL) was created to respond to this urgent need. A team of scientists and doctors from McMaster University, the Research Institute of St. Joseph’s Hamilton, and other Canadian universities and research organizations came together to generate the scientific data critical to developing innovative ways to keep Canadians safe and to support a strong economy.
Dr. Jack Gauldie, Distinguished University Professor, Pathology and Molecular Medicine, McMaster University; and Dr. Marek Smieja, Microbiologist and Professor, Pathology and Molecular Medicine, McMaster University helped bring together some of the brightest minds to create MHL.
MHL is a non-profit organization. We have partnerships and research initiatives with large health care and manufacturing organizations, and an important study supported by Air Canada and The Greater Toronto Airports Authority. Our aim is to help Canadian businesses create safe places of work through operational research and delivery of COVID-19 testing